Dermatopathology of COVID-19 infection and vaccination

Tan SW, Tam YC, Oh CC (2021) Skin manifestations of COVID-19: a worldwide review. JAAD Int 2:119–133

Fernandez-Nieto D, Ortega-Quijano D, Suarez-Valle A et al (2021) Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV‑2 variant—a cross-sectional study. J Eur Acad Dermatol Venereol 35:e183–e185

Wang CJ, Worswick S (2021) Cutaneous manifestations of COVID-19. Dermatol Online J 27:13030/qt2m54r7nv

Gambichler T, Boms S, Susok L et al (2022) Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. Acad Dermatol Venereol 36:172–180

Galván Casas C, Català A, Carretero Hernández G et al (2020) Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 183:71–77

Battesti G, El Khalifa J, Abdelhedi N et al (2020) New insights in COVID-19-associated chilblains: a comparative study with chilblain lupus erythematosus. J Am Acad Dermatol 83:1219–1222

Seirafianpour F, Sodagar S, Pour MA et al (2020) Cutaneous manifestations and considerations in COVID-19 pandemic: a systematic review. Dermatol Ther 33:e13986

Gehlhausen JR, Little AJ, Ko CJ et al (2022) Lack of association between pandemic chilblains and SARS-CoV‑2 infection. Proc Natl Acad Sci U S A 119:e2122090119

Kolivras A, Dehavay F, Delplace D et al (2020) Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings. JAAD Case Rep 6:489–492

Rongioletti F, Ferreli C, Sena P et al (2021) Clinicopathologic correlations of COVID-19–related cutaneous manifestations with special emphasis on histopathologic patterns. Clin Dermatol 39:149–162

Fernandez-Nieto D, Ortega-Quijano D, Jimenez-Cauhe J et al (2020) Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol 45:872–875

Llamas-Velasco M, Chicharro P, Rodríguez-Jiménez PM et al (2020) Comment on “Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital”. Pseudoherpetic Grover disease seems to occur in patients with COVID-19 infection. Clin Exp Dermatol 45:896–898

Egido-Moreno S, Valls-Roca-Umbert J, Jané-Salas E et al (2021) COVID-19 and oral lesions, short communication and review. J Clin Exp Dent 13:e287–e294

Andina D, Belloni-Fortina A, Bodemer C et al (2021) Skin manifestations of COVID-19 in children: part 3. Clin Exp Dermatol 46:462–472

Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G (2021) New onset of autoimmune diseases following COVID-19 diagnosis. Cells 10:3592

Florenzo B, Martin S, Saavedra A (2022) Reactivated chronic graft-versus-host disease following SARS-coV‑2 infection. JAAD Case Rep. https://doi.org/10.1016/j.jdcr.2022.06.015

Fernández-Figueras M‑T, Moreno JA, Pérez-Muñoz N et al (2021) Disseminated inflammatory lesions in 2 patients with COVID-19: answer. Am J Dermatopathol 43:459–460

Lee JY, Ang ASY, Mohd AN et al (2021) Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study. J of Pharm Policy and Pract 14:84

Ohadi L, Hosseinzadeh F, Dadkhahfar S, Nasiri S (2022) Oncolytic effect of SARS-CoV‑2 in a patient with mycosis fungoides: a case report. Clin Case Rep 10:e5682

Snowden C, Ng S, Choi J (2022) Partial remission of advanced untreated Sézary syndrome after COVID-19. JAAD Case Rep 21:165–168

Sun Q, Fathy R, McMahon DE, Freeman EE (2021) COVID-19 vaccines and the skin. Dermatol Clin 39:653–673

Freeman EE, Sun Q, McMahon DE et al (2022) Skin reactions to COVID-19 vaccines: an American Academy of Dermatology/International League of Dermatological Societies registry update on reaction location and COVID vaccine type. J Am Acad Dermatol 86:e165–e167

Kempf W, Kettelhack N, Kind F et al (2021) ‘COVID arm’—histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine. J Eur Acad Dermatol Venereol 35:e730–e732

Chen Y, Xu Z, Wang P et al (2022) New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology 165:386–401

Lee E, Cines DB, Gernsheimer T et al (2021) Thrombocytopenia following Pfizer and Moderna SARS-CoV‑2 vaccination. Am J Hematol 96:534–537

McMahon DE, Amerson E, Rosenbach M et al (2021) Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol 85:46–55

Kong J, Cuevas-Castillo F, Nassar M et al (2021) Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: case report. J Infect Public Health 14:1392–1394

Merrill ED, Kashem SW, Amerson EH et al (2021) Association of facial pustular neutrophilic eruption with messenger RNA-1273 SARS-CoV‑2 vaccine. JAMA Dermatol 157:1128–1130

Panou E, Nikolaou V, Marinos L et al (2022) Recurrence of cutaneous T‑cell lymphoma post viral vector COVID-19 vaccination. Acad Dermatol Venereol 36:e91–e93

Aouali S, Benkaraache M, Almheirat Y et al (2022) Complete remission of primary cutaneous follicle centre cell lymphoma associated with COVID-19 vaccine. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.18246